Physician profile
Benjamin Rushing
NPI 1073254256
$1,608.18
in general payments reported to CMS, 2019-2025
11 companies · $981 in 2025
The $981 reported for 2025 was more than what 88% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $24.80 · 2023: $392 · 2024: $210 · 2025: $981.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,583.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,583.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $462.14 | 2023-2025 | |
| Ucb, INC. | $191.05 | 2023-2025 | Bimzelx, Cimzia |
| Novartis Pharmaceuticals Corporation | $169.58 | 2024-2025 | |
| Pfizer INC. | $158.86 | 2024-2025 | |
| Abbvie INC. | $148.98 | 2022-2025 | |
| Incyte Corporation | $124.36 | 2025 | |
| Organon LLC | $123.82 | 2025 | Vtama |
| Mallinckrodt Hospital Products INC. | $91.56 | 2023 | Uvadex |
| Janssen Scientific Affairs, LLC | $64.82 | 2025 | Tremfya |
| Lilly USA, LLC | $53.02 | 2025 | Ebglyss |
| Galderma Laboratories, L.P. | $19.99 | 2025 | Nemluvio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Rushing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.